ArticleCancer prevention research (Philadelphia, Pa.)2009

Synergistic growth inhibition of squamous cell carcinoma of the head and neck by erlotinib and epigallocatechin-3-gallate: the role of p53-dependent inhibition of nuclear factor-kappaB.

A R M Ruhul Amin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.